These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Novel and Effective Therapeutic Regimens for Hu Y; Zhu Y; Lu NH Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929 [No Abstract] [Full Text] [Related]
10. Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy. Hsu PI; Chen WC; Tsay FW; Shih CA; Kao SS; Wang HM; Yu HC; Lai KH; Tseng HH; Peng NJ; Chen A; Kuo CH; Wu DC; Helicobacter; 2014 Feb; 19(1):74-9. PubMed ID: 24033865 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era. Georgopoulos SD; Papastergiou V; Karatapanis S Expert Opin Pharmacother; 2015; 16(15):2307-17. PubMed ID: 26330278 [TBL] [Abstract][Full Text] [Related]
12. High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand. Prapitpaiboon H; Mahachai V; Vilaichone RK Asian Pac J Cancer Prev; 2015; 16(10):4353-6. PubMed ID: 26028098 [TBL] [Abstract][Full Text] [Related]
13. Current and future insights in H. pylori eradication regimens: the need of tailoring therapy. Papastergiou V; Georgopoulos SD; Karatapanis S Curr Pharm Des; 2014; 20(28):4521-32. PubMed ID: 24180408 [TBL] [Abstract][Full Text] [Related]
15. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Fallone CA; Chiba N; van Zanten SV; Fischbach L; Gisbert JP; Hunt RH; Jones NL; Render C; Leontiadis GI; Moayyedi P; Marshall JK Gastroenterology; 2016 Jul; 151(1):51-69.e14. PubMed ID: 27102658 [TBL] [Abstract][Full Text] [Related]
16. 'Rescue' therapies for the management of Helicobacter pylori infection. Di Mario F; Cavallaro LG; Scarpignato C Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270 [TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Gisbert JP; Romano M; Gravina AG; Solís-Muñoz P; Bermejo F; Molina-Infante J; Castro-Fernández M; Ortuño J; Lucendo AJ; Herranz M; Modolell I; Del Castillo F; Gómez J; Barrio J; Velayos B; Gómez B; Domínguez JL; Miranda A; Martorano M; Algaba A; Pabón M; Angueira T; Fernández-Salazar L; Federico A; Marín AC; McNicholl AG Aliment Pharmacol Ther; 2015 Apr; 41(8):768-75. PubMed ID: 25703120 [TBL] [Abstract][Full Text] [Related]
18. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial. Hsu PI; Tsai FW; Kao SS; Hsu WH; Cheng JS; Peng NJ; Tsai KW; Hu HM; Wang YK; Chuah SK; Chen A; Wu DC Am J Gastroenterol; 2017 Sep; 112(9):1374-1381. PubMed ID: 28719592 [TBL] [Abstract][Full Text] [Related]